<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="Two%20type%20of%20vitiligo%20blog_files/filelist.xml">
<link rel=Edit-Time-Data
href="Two%20type%20of%20vitiligo%20blog_files/editdata.mso">

<link rel=dataStoreItem
href="Two%20type%20of%20vitiligo%20blog_files/item0001.xml"
target="Two%20type%20of%20vitiligo%20blog_files/props002.xml">
<link rel=themeData
href="Two%20type%20of%20vitiligo%20blog_files/themedata.thmx">
<link rel=colorSchemeMapping
href="Two%20type%20of%20vitiligo%20blog_files/colorschememapping.xml">

<link rel=plchdr href="Two%20type%20of%20vitiligo%20blog_files/plchdr.htm">
<style>
<!--
  
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1107305727 0 0 415 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073786111 1 0 415 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520084737 -1073683329 41 0 479 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
  
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:0pt;
	font-weight:normal;}
h2
	{mso-style-priority:6;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	font-size:13.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#323E4F;
	mso-themecolor:text2;
	mso-themeshade:191;
	font-weight:bold;}
h3
	{mso-style-priority:7;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-outline-level:3;
	font-size:11.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#323E4F;
	mso-themecolor:text2;
	mso-themeshade:191;
	font-weight:bold;}
h4
	{mso-style-priority:8;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-outline-level:4;
	font-size:11.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#323E4F;
	mso-themecolor:text2;
	mso-themeshade:191;
	font-weight:normal;}
h5
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-outline-level:5;
	font-size:11.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#323E4F;
	mso-themecolor:text2;
	mso-themeshade:191;
	font-weight:normal;
	font-style:italic;}
h6
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	mso-outline-level:6;
	font-size:10.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#323E4F;
	mso-themecolor:text2;
	mso-themeshade:191;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#0563C1;
	mso-themecolor:hyperlink;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-priority:1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.MsoPlaceholderText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	color:gray;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:10.0pt;
	margin-left:.5in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:black;
	mso-themecolor:text1;}
p.Publishwithline, li.Publishwithline, div.Publishwithline
	{mso-style-name:"Publish with line";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:16.0pt;
	mso-bidi-font-size:19.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#262626;
	font-weight:bold;}
p.PublishStatus, li.PublishStatus, div.PublishStatus
	{mso-style-name:"Publish Status";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:5.0pt;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#F0F0F0;
	border:none;
	mso-border-top-alt:#E1E1E1;
	mso-border-left-alt:#F0F0F0;
	mso-border-bottom-alt:#E1E1E1;
	mso-border-right-alt:#F0F0F0;
	mso-border-style-alt:solid;
	mso-border-width-alt:1.0pt;
	padding:0in;
	mso-padding-alt:1.0pt 2.0pt 1.0pt 2.0pt;
	font-size:9.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:#444444;}
p.PublishStatusAccessible, li.PublishStatusAccessible, div.PublishStatusAccessible
	{mso-style-name:PublishStatus_Accessible;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:5.0pt;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-alt:solid #444444 .5pt;
	padding:0in;
	mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt;
	font-size:9.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.Account, li.Account, div.Account
	{mso-style-name:Account;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:.05in 63.35pt;
	font-size:9.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-fareast-font-family:"Segoe UI";
	color:#666666;}
p.Categories, li.Categories, div.Categories
	{mso-style-name:Categories;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:Account;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:.05in 63.35pt;
	font-size:9.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-fareast-font-family:"Segoe UI";
	color:#666666;}
p.PadderBetweenTitleandProperties, li.PadderBetweenTitleandProperties, div.PadderBetweenTitleandProperties
	{mso-style-name:"Padder Between Title and Properties";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.PadderBetweenControlandBody, li.PadderBetweenControlandBody, div.PadderBetweenControlandBody
	{mso-style-name:"Padder Between Control and Body";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.underline, li.underline, div.underline
	{mso-style-name:underline;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-bottom-alt:solid #C6C6C6 1.0pt;
	padding:0in;
	mso-padding-alt:0in 0in 2.0pt 0in;
	font-size:1.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#2E74B5;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:SimSun;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:10.0pt;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
  
 @list l0
	{mso-list-id:72817546;
	mso-list-type:hybrid;
	mso-list-template-ids:580036320 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l0:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l0:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l0:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l0:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l0:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l0:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l0:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l0:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l1
	{mso-list-id:391739792;
	mso-list-type:hybrid;
	mso-list-template-ids:-1697896966 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link="#0563C1" vlink="#954F72" style='tab-interval:.5in'>

<div class=WordSection1><w:Sdt SdtLocked="t" ContentLocked="t" SdtGroup="t"
 ID="89512093">
 <div style='mso-element:para-border-div;border-top:#E1E1E1;border-left:#F0F0F0;
 border-bottom:#E1E1E1;border-right:#F0F0F0;border-style:solid;border-width:
 1.0pt;padding:1.0pt 2.0pt 1.0pt 2.0pt;background:#F0F0F0'>
 <p class=PublishStatus>This post was republished to ge600 at 6:33:20 PM
 5/28/2016<span style='font-size:1.0pt;mso-ascii-font-family:Calibri;
 mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;mso-hansi-theme-font:
 minor-latin;color:windowtext'><w:sdtPr></w:sdtPr></span></p>
 </div>
 <w:Sdt Xpath="/ns0:BlogPostInfo/ns0:PostTitle" DocPart="89512082" Text="t"
  StoreItemID="X_5F329CAD-B019-4FA6-9FEF-74898909AD20" Title="Post Title"
  ID="89512082">
  <p class=Publishwithline><span style='mso-bidi-font-size:16.0pt;color:#2E74B5;
  mso-themecolor:accent1;mso-themeshade:191'>Treatment of vitiligo: a summary
  of medical literature</span><span style='mso-bidi-font-size:16.0pt;
  color:#2E74B5;mso-themecolor:accent1;mso-themeshade:191'><w:sdtPr></w:sdtPr></span></p>
 </w:Sdt>
 <div style='mso-element:para-border-div;border:none;border-bottom:solid #C6C6C6 1.0pt;
 padding:0in 0in 2.0pt 0in'>
 <p class=underline><o:p>&nbsp;</o:p></p>
 </div>
 <p class=PadderBetweenControlandBody><o:p>&nbsp;</o:p></p>
</w:Sdt>

<p class=MsoNormal>As a scientist who also suffers from vitiligo, I spent a day
trying to read the current SCIENTIFIC findings published in peer-reviewed scientific
journals. </p>

<p class=MsoListParagraphCxSpFirst style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level1 lfo1'>&lt;![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;![endif]>Two type of vitiligo: segmental (localized) vs.
non-segmental. Most are non-segmental. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level1 lfo1'>&lt;![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;![endif]>There are evidence that vitiligo patients are
low in <span class=MsoHyperlink><a
href="http://www.ncbi.nlm.nih.gov/pubmed/27057010">antioxidants</a></span>, <span
class=MsoHyperlink><a href="http://www.ncbi.nlm.nih.gov/pubmed/26422855">vitamin
D</a></span>, <span class=MsoHyperlink><a
href="http://www.ncbi.nlm.nih.gov/pubmed/24517587">zinc and copper</a></span>.
Vitiligo patients often suffer low glutathione peroxidase (<span class=SpellE>GPx</span>)
as suggested by <span class=MsoHyperlink><a
href="http://www.ncbi.nlm.nih.gov/pubmed/27218102">this</a></span> and other
papers. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level1 lfo1'>&lt;![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;![endif]>Vitiligo is loss of pigmentation in the skin.
Loss of a type of cells called melanocyte that produces melanin. Pathology is
unclear, but evidence is strong for autoimmune disease. In other words, our own
immune cells attack melanocytes. Oxidative stress by reactive oxygen species
might play a role. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level1 lfo1'>&lt;![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;![endif]>There is no cure for vitiligo. But <b
style='mso-bidi-font-weight:normal'>most</b> patients see improvements with
current treatments. It may take months. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:.25in;mso-add-space:
auto;text-indent:-.25in;mso-list:l1 level1 lfo1'>&lt;![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;![endif]>Many treatment exits, but few are rigorously
tested in controlled clinical trials.<span style='mso-spacerun:yes'> 
</span>Scientifically sound results published in peer-reviewed scientific
journals are available in PubMed.org. </p>

<p class=MsoListParagraphCxSpLast style='margin-left:.25in;mso-add-space:auto;
text-indent:-.25in;mso-list:l1 level1 lfo1'>&lt;![if !supportLists]><span
style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;![endif]>Standard treatment protocols recommended by
scientists and doctors, such as the <span class=MsoHyperlink><a
href="http://www.espcr.org/vetf/">Vitiligo European Task Force</a></span>. The
following charts are from a book “Pigmentary Disorders: A Comprehensive
Compendium” by Koushik <span class=SpellE>Lahiri</span>, <span class=SpellE>Manas</span>
Chatterjee, Rashmi <span class=SpellE>Sarka</span>. </p>

<p class=MsoNormal><span style='mso-no-proof:yes'>&lt;![if !vml]><img border=0 width=565 height=493
src="Two%20type%20of%20vitiligo%20blog_files/image002.jpg" v:shapes="Picture_x0020_1">&lt;![endif]></span></p>

<p class=MsoNormal><span style='mso-no-proof:yes'>&lt;![if !vml]><img border=0 width=520 height=489
src="Two%20type%20of%20vitiligo%20blog_files/image004.jpg" v:shapes="Picture_x0020_2">&lt;![endif]></span></p>

<p class=MsoNormal><span style='mso-no-proof:yes'>&lt;![if !vml]><img border=0 width=404 height=348
src="Two%20type%20of%20vitiligo%20blog_files/image006.jpg" v:shapes="Picture_x0020_3">&lt;![endif]></span></p>

<p class=MsoNormal><span style='font-family:"Times New Roman",serif'>As can be
seen from these two figures, the most widely used therapies are: Narrow-band
ultraviolet B (NB-UVB), topical corticosteroid, topical calcineurin inhibitors.<o:p></o:p></span></p>

<p class=MsoNormal><span style='font-family:"Times New Roman",serif'>These
therapies can be classified into the following categories:<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in;mso-list:l0 level1 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]><b
style='mso-bidi-font-weight:normal'>Phototherapy</b> uses different lights to
treat vitiligo. Narrow-band ultraviolet B (NB-UVB) is one of the most effective
methods. It can be targeted to small areas or whole body.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]><b
style='mso-bidi-font-weight:normal'>Topical therapies</b> such as topical
corticosteroid, topical calcineurin inhibitors (Tacrolimus, <span class=SpellE><span
class=GramE>pimecrolimus</span></span><span class=GramE><span
style='mso-spacerun:yes'>  </span><span class=SpellE><i style='mso-bidi-font-style:
normal'>etc</i></span></span>) are effective for selected areas. But not for
long term use. These are standard recommended methods to try first for
segmental vitiligo, small, limited patches. For large areas of vitiligo
throughout the body, the standard method is NB-UVB for 3 months, in combination
with topical therapies. </p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]><b
style='mso-bidi-font-weight:normal'>Systemic treatment </b>can be done through
oral medicines such as corticosteroids. <u>Oral corticosteroids</u> are shown
to stop the progression of vitiligo and induce <span class=SpellE>repigmentation</span>.
But side effects are a concern. <u>Antioxidants</u>, either oral or topical,
can help protect against reactive oxygen species that are believed to cause
vitiligo. </p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]><b
style='mso-bidi-font-weight:normal'>Surgical therapy. </b>Transplant of skins
or even <span class=MsoHyperlink><a
href="http://www.ncbi.nlm.nih.gov/pubmed/26865785">hair follicular</a></span>.
Methods such as suction blister epidermal grafts are very effective and safe. <b
style='mso-bidi-font-weight:normal'><span style='mso-spacerun:yes'> </span></b></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]><b
style='mso-bidi-font-weight:normal'>Camouflage.</b> Cosmetic camouflage
improves quality of life. Some are permanent (tattoos, and micropigmentation)
should be used with caution. Using <span class=MsoHyperlink><a
href="http://www.dermnetnz.org/treatments/dihydroxyacetone.html">DHA creams</a></span>
to camouflage seem to be <span class=MsoHyperlink><a
href="http://www.ncbi.nlm.nih.gov/pubmed/18377610">safe and effective</a></span>.
These creams are used in self-tanning and will last 5-7 days. </p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]><b
style='mso-bidi-font-weight:normal'>Combination therapy </b>combines these
methods. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;mso-add-space:
auto;text-indent:-.25in;mso-list:l0 level2 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>a.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]>Topical
creams are often combined with phototherapy.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;mso-add-space:
auto;text-indent:-.25in;mso-list:l0 level2 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>b.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]>Oral
MPD mini-pulse therapy combined with NBUVB appears effective in
arresting&nbsp;vitiligo&nbsp;progression and rapidly inducing <span
class=SpellE>repigmentation</span> with minimal side effects.</p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;mso-add-space:
auto;text-indent:-.25in;mso-list:l0 level2 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>c.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]>The
combined treatment with oral ALA, betamethasone injection, and NB-UVB was
effective and safe on non-segmental progressive&nbsp;vitiligo. ALA could
accelerate the initial response of <span class=SpellE>repigmentation</span>.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in;mso-list:l0 level1 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>7.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]><b
style='mso-bidi-font-weight:normal'>Alternative therapy. </b><span
class=MsoHyperlink><a href="http://www.ncbi.nlm.nih.gov/pubmed/18498646">Many</a></span>
are being tested. But their effectiveness are not well supported. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;mso-add-space:
auto;text-indent:-.25in;mso-list:l0 level2 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>a.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]>Diet
supplements such as Vitamin C, E, <span class=SpellE>ginko</span> biloba
extracts. Supplements for zinc and copper. L-phenylalanine used with
phototherapy, and oral Ginkgo biloba as monotherapy show promise. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;mso-add-space:
auto;text-indent:-.25in;mso-list:l0 level2 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>b.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]>Some
Chinese herbal medicines act as photosensitizing agents to induce effects like
sun burn to treat vitiligo. </p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;mso-add-space:
auto;text-indent:-.25in;mso-list:l0 level2 lfo2'>&lt;![if !supportLists]><span
style='mso-fareast-font-family:"Times New Roman"'><span style='mso-list:Ignore'>c.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span>&lt;![endif]>Combine
vitamin E with phototherapy</p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.0in;mso-add-space:auto'><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>
